DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Receives Average Rating of “Moderate Buy” from Brokerages

Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) have received an average recommendation of “Moderate Buy” from the eleven ratings firms that are currently covering the firm, Marketbeat reports. Four equities research analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average twelve-month target price among brokerages that have covered the stock in the last year is $32.67.

Several analysts have recently issued reports on the company. Stifel Nicolaus decreased their price target on DENTSPLY SIRONA from $30.00 to $28.00 and set a “hold” rating for the company in a research note on Thursday, July 18th. Needham & Company LLC decreased their target price on DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating for the company in a research note on Friday. Robert W. Baird decreased their target price on DENTSPLY SIRONA from $33.00 to $31.00 and set a “neutral” rating for the company in a research note on Monday, July 22nd. Barrington Research restated an “outperform” rating and set a $36.00 target price on shares of DENTSPLY SIRONA in a research note on Friday, September 20th. Finally, Evercore ISI decreased their target price on DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating for the company in a research note on Tuesday, October 8th.

Hedge Funds Weigh In On DENTSPLY SIRONA

Several large investors have recently added to or reduced their stakes in the company. First Eagle Investment Management LLC raised its holdings in DENTSPLY SIRONA by 33.6% in the 2nd quarter. First Eagle Investment Management LLC now owns 13,069,900 shares of the medical instruments supplier’s stock valued at $325,571,000 after acquiring an additional 3,283,965 shares in the last quarter. Nuance Investments LLC raised its holdings in DENTSPLY SIRONA by 3.8% in the 2nd quarter. Nuance Investments LLC now owns 10,879,916 shares of the medical instruments supplier’s stock valued at $271,019,000 after acquiring an additional 402,329 shares in the last quarter. Cooke & Bieler LP raised its holdings in DENTSPLY SIRONA by 16.2% in the 2nd quarter. Cooke & Bieler LP now owns 7,506,845 shares of the medical instruments supplier’s stock valued at $186,996,000 after acquiring an additional 1,046,105 shares in the last quarter. Price T Rowe Associates Inc. MD raised its holdings in DENTSPLY SIRONA by 5.8% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 6,266,781 shares of the medical instruments supplier’s stock valued at $207,995,000 after acquiring an additional 343,915 shares in the last quarter. Finally, Dimensional Fund Advisors LP raised its holdings in shares of DENTSPLY SIRONA by 42.0% in the 2nd quarter. Dimensional Fund Advisors LP now owns 4,420,445 shares of the medical instruments supplier’s stock worth $110,118,000 after buying an additional 1,308,411 shares in the last quarter. Institutional investors and hedge funds own 95.70% of the company’s stock.

DENTSPLY SIRONA Stock Performance

XRAY opened at $23.31 on Friday. The company has a market cap of $4.73 billion, a PE ratio of -27.10, a price-to-earnings-growth ratio of 1.17 and a beta of 1.00. The stock has a 50-day moving average of $25.22 and a 200-day moving average of $26.47. DENTSPLY SIRONA has a 52-week low of $22.85 and a 52-week high of $37.60. The company has a debt-to-equity ratio of 0.57, a quick ratio of 0.87 and a current ratio of 1.33.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings results on Wednesday, July 31st. The medical instruments supplier reported $0.49 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.50 by ($0.01). The company had revenue of $984.00 million for the quarter, compared to the consensus estimate of $993.61 million. DENTSPLY SIRONA had a positive return on equity of 11.86% and a negative net margin of 4.75%. The business’s revenue was down 4.3% compared to the same quarter last year. During the same quarter last year, the company posted $0.51 EPS. As a group, equities research analysts forecast that DENTSPLY SIRONA will post 1.98 earnings per share for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, October 11th. Shareholders of record on Friday, September 27th were issued a $0.16 dividend. The ex-dividend date of this dividend was Friday, September 27th. This represents a $0.64 annualized dividend and a yield of 2.75%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is -74.42%.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.